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Abstract
Objective: To evaluate the differences between non-circular shape of FloWatch1-PAB and conventional pulmonary artery (PA) banding.
Methods: Geometrical analysis. Conventional banding and FloWatch1-PAB perimeters were plotted against cross-sections. Computational fluid
dynamics (CFD) model. CFD compared non-circular FloWatch1-PAB cross-sections with conventional banding regarding pressure gradients.
Clinical data. Seven children, median age 2months (7 days to 3 years), median weight 4.2 kg (3.2—9.8 kg), with complex congenital heart defects
underwent PA banding with FloWatch1-PAB implantation. Results: Geometrical analysis. Conventional banding: progressive reduction of cross-
sections was accompanied by progressive reduction of PA perimeters. FloWatch1-PAB: with equal reduction of cross-sections the PA perimeter
remained constant. CFD model. Non-circular and circular banding provided same trans-banding pressure gradients for same cross-sections at any
given flow. Clinical data. Mean PA internal diameter at banding was 13.3  4.5 mm. After a mean interval of 5.9  3.7 months, all children
underwent intra-cardiac repair and simple FloWatch1-PAB removal without PA reconstruction. Mean PA internal diameter with FloWatch1-PAB
removal increased from 3.0  0.8 to 12.4  4.5 mm (normal mean internal diameter for the age = 9.9  1.6). No residual pressure gradient was
recorded in correspondence of the site of the previous FloWatch1-PAB implantation in 6/7 patients, 10 mmHg peak and 5 mmHgmean gradient in
1/7. Conclusions: The non-circular shape of FloWatch1-PAB can replace conventional circular banding with the following advantages: (a) the
pressure gradient will remain essentially the same as for conventional circular banding for any given cross-section, but with significantly smaller
reduction of PA perimeter; and (b) PA reconstruction at the time of de-banding for intra-cardiac repair can be avoided.
# 2005 Elsevier B.V. All rights reserved.
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Recent clinical reports considered the pulmonary artery
(PA) banding as a palliative approach not only for classical
indications such as functionally univentricular hearts [1,2]
but also for more controversial situations such as multiple
ventricular septal defects [3] and complete atrio-ventricular
septal defects [4].
Increasing interest for pulmonary artery banding has been
recently dictated by the need for left ventricular retraining
in transposition of the great arteries with late referral [5] and
in congenitally corrected transposition of the great arteries
(=double discordance) [6].* Corresponding author. Tel.: +44 151 2525713; fax: +44 151 2525643.
E-mail address: Antonio.Corno@rlc.nhs.uk (A.F. Corno).
1010-7940/$ — see front matter # 2005 Elsevier B.V. All rights reserved.
doi:10.1016/j.ejcts.2005.10.029New indications for pulmonary artery banding have been
considered in hypoplastic left heart malformations, either as
a rescue procedure in critical neonates or as an elective
preparation for the subsequent surgical stage, either Nor-
wood procedure or heart transplant [7—9].
The problem most frequently complicating the manage-
ment of neonates and infants requiring a pulmonary artery
banding was the need for an adjustable banding, particularly
evident in functionally univentricular hearts and in left
ventricular retraining. This need has been solved, at least
for neonates and infants, with the clinical availability of a
telemetrically controlled, adjustable pulmonary artery band-
ing (FloWatch1-PAB, EndoArt, Lausanne, Switzerland), suc-
cessfully tested in clinical practice in different institutions
[10—13]afterpositiveexperimentalevaluation inanimals [14].
Another limit of the conventional pulmonary artery
banding was the need for main pulmonary artery reconstruc-
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[15—18], with extension of the operative duration and risk of
residual or recurrent pressure gradient requiring additional
interventional procedure or re-operation [16—18].
In this study, we evaluated the need for pulmonary artery
reconstruction at themoment of de-banding as a result of the
use of the FloWatch1-PAB for pulmonary artery banding. A
geometrical analysis of the FloWatch1-PAB banding shape
and the support of computational fluid dynamics (CFD) were
used to better understand the observations coming from the
clinical practice.Fig. 1. The geometry of the computational model in the region of the banding
with 50% occlusion of FloWatch1-PAB (top) and after FloWatch1-PAB removal
(bottom). The hypothesis of constant perimeter at the banding level was used
in both these two situations.2. Materials and methods
2.1. Geometrical analysis
The banding shape of the FloWatch1-PAB implant at
different levels of constriction was obtained by a digital
camera (Nikon E5700, Nikon Corp., Japan). These pictures
were calibrated by using a rectangular reference on each
picture. The cross-sectional areas and the perimeters were
then obtained from a standard analysis computer program
(Mathematica, Wolfram Research Inc., USA). These data
were used to plot the FloWatch1-PAB perimeters in function
of the cross-sections. They were also used as geometrical
parameters for the CFD model. It is worth noting that these
perimeters are external perimeters with respect to the
pulmonary artery wall, and the cross-sectional areas include
the arterial wall cross-section. In the following CFD model
and the clinical data, all the diameters will be internal
diameters and the cross-sectional areas will exclude the
arterial wall cross-section.
2.2. Computational fluid dynamics model
Fundamental fluid dynamics or hemodynamics show that
the cross-sectional area of a vessel is related to the pressure
drop between two different cross-sections of the vessel at
hand. According to the fact that the pressure drop along the
pulmonary artery is a clinically relevant quantity, we have
chosen to quantify by means of CFD the pressure drop across
the pulmonary artery in different banding conditions:
pulmonary artery before banding, with circular banding,
with FloWatch1-PAB at different configurations and after
FloWatch1-PAB removal.
CFD has been applied considering a geometrical model for
the pulmonary artery where the proximal section corre-
sponds to the pulmonary valve and the distal section is taken
upstream with respect to the pulmonary artery bifurcation.
The diameter of the arterial lumen (D) is 18 mm and the
length of the pulmonary artery is 4  D, with the position of
the banding assumed in the middle of the pulmonary artery.
The extent of the contraction region and the expansion
region is 1  D. The geometrical shape of the banding was
taken from the previously described calibrated pictures,
assuming a constant thickness of the pulmonary artery of
0.5 mm inside the FloWatch1-PAB narrowing.
To describe the blood flow, the mathematical model
employed the time-dependent, three-dimensional, incom-
pressible Navier—Stokes equations [19]. This system ofequations must be provided with suitable boundary and
initial conditions. At the flow entrance, fully developed
velocity profiles are considered. The arterial wall is
considered to be rigid and the no-slip condition is applied.
The numerical solution of the time-dependent Navier—
Stokes equations was performed by the finite element
method. Fig. 1 demonstrates the local high refinement of the
finite element subdivision needed to capture the high
velocity gradients in case of high cross-sectional restrictions
(50% occlusion of FloWatch1-PAB).
For a rigorous mathematical definition of this method and
its application to fluid dynamics, we refer to previous
publications [20] as well for its specific application to blood
flow [19].
2.3. Clinical data
Seven children with complex congenital heart defects,
most with a late referral (Table 1), underwent pulmonary
artery banding with FloWatch1-PAB implantation followed by
subsequent intra-cardiac repair with de-banding (Flo-
Watch1-PAB removal).
In all patients the internal diameter of the main
pulmonary artery has been measured with standard surface
two-dimensional echocardiography and with intra-operative
trans-oesophageal echocardiography in three different
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Table 1
Clinical data
Patient Age Weight (kg) Diagnosis
L.P. 2 months 4.2 Multiple ventricular septal defects
A.H. 2 months 3.7 Double inlet single ventricle,
transposition of the great arteries
R.V. 2 months 3.2 Transposition of the great arteries
J.B. 7 days 3.2 Ventricular septal defect, aortic
stenosis, hypoplastic aortic arch
A.N. 3 years 9.8 Double outlet right ventricle,
uncommitted ventricular septal
defect, straddling tricuspid valve,
anomalous left anterior coronary
artery from the right coronary artery,
severe pulmonary hypertension
L.S. 6 months 6.2 Transposition of the great arteries
A.S.C. 10 months 6.1 Transposition of the great arteriesperiods: (a) before FloWatch1-PAB implantation for pulmon-
ary artery banding; (b) before pulmonary artery de-banding
(FloWatch1-PAB removal); and (c) after pulmonary artery de-
banding (FloWatch1-PAB removal); in the last occasion a
Doppler echocardiography has been associated to measure
residual pressure gradients across the main pulmonary artery
in the site of the previously implanted banding. The
‘‘diameter’’ before pulmonary artery de-banding is by
definition the short axis of the ‘‘banana-shape’’ of the
FloWatch1-PAB. This measurement should be considered as
indicative as this ‘‘banana-shape’’ is not univocally described
by a diameter. Nevertheless, we consider this measurement
as a reliable measure of the degree of banding and it has been
reported because of its clinical relevance.
All values of the diameter of the main pulmonary artery
have been recorded, as also recording of the pressure
gradients after de-banding.Fig. 2. Geometrical analysis: the length of the external perimeter of the banding plo
banding and for the FloWatch1-PAB banding. The cross-section range considered is the
section range and the exact perimeters at these cross-sections are given at the samThe study has been conducted after approval by the local
institutional review board.
2.4. Statistical analysis
Values have been reported as mean  standard deviation.
Comparisons were made with Student’s t-test. Differences
were considered to be significant for P < 0.05.3. Results
3.1. Geometrical analysis
The length of the external perimeter of the banding was
plotted against the cross-sectional area of the banding for a
conventional circular banding and for the FloWatch1-PAB
banding (Fig. 2). While with conventional banding the
progressive reduction of the cross-sectional area was
accompanied by a progressive reduction of the perimeters
of the pulmonary artery, with FloWatch1-PAB for equal
reduction of cross-sectional areas the PA perimeter remained
constant.
This is due to the non-circular shape (banana-shape, see
Fig. 2) of the FloWatch1-PAB banding. This banana-shape
allows for a fairly constant perimeter on all the banding range
of the device, in contrary to the conventional circular
banding. In addition, this constant perimeter is larger than
the maximum perimeter of the circular banding for the same
range of cross-sectional areas. The constant perimeter of the
FloWatch1-PAB corresponds to a circular banding of 12.4 mm
in diameter, which has a cross-section of 120 mm2, while the
FloWatch1-PAB banding, for the same perimeter, allows a
reduction of the cross-sectional area from 72 to 38 mm2.
Assuming a constant wall thickness of 0.5 mm for thetted against the cross-sectional area of the banding for a conventional circular
one accessible to the FloWatch1-PAB. The shapes of the extremity of the cross-
e scale for both the FloWatch1-PAB and the conventional circular banding.
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Fig. 3. Computational investigation of the dependence of the pressure gra-
dients across a narrowing of the pulmonary artery induced by the banding and
the cross-sectional area at the minimal section, for different percent of
occlusion: 26%, 50% and 62%. The measurements were obtained with two
different flows: 1.5 and 2.0 L/min. Fig. 4. Comparison of the axial flow velocity between FloWatch
1-PAB with 50%
occlusion (top) and conventional circular banding with the same cross-sec-
tional area (bottom), showing a significant difference of the axial velocity
profiles between the two. The special cross-sectional shape of FloWatch1-PAB
results into two jets downstream (cross-section C), while in the conventional
banding a single velocity jet with a higher peak velocity occurs.development of the computational model, the result is a
variable luminal cross-sectional area from 52 to 18 mm2.
3.2. Computational fluid dynamics model
In order to investigate the influence of the banding shape
on the pressure gradient across the banding, several
simulations have been carried out in different geometrical
configurations. Fig. 3 displays the resulting pressure gradient
for three different FloWatch1-PAB occlusion levels, resulting
in a luminal cross-sectional area of 47 mm2 (26% occlusion),
39 mm2 (50% occlusion) and 36 mm2 (62% occlusion). For each
geometrical configuration, two numerical simulations with a
different inflow rate (1.5 and 2.0 L/min) have been carried
out. The figure points out that the resulting pressure
gradients across the banding are more sensitive to varying
FloWatch1-PAB occlusions in case of a higher flow rate,
resulting in a higher slope of the curve, in perfect agreement
with Poiseuille’s law [19]. The difference of the pressure
gradients between FloWatch1-PAB and conventional circular
banding is shown in Table 2. The differences of the pressure
gradients are within 13% for comparable configurations (same
luminal cross-sectional area). Thereafter, the computationalTable 2
Difference of the mean trans-banding pressure gradient between FloWatch1-
PAB and conventional circular banding
Mean trans-banding
pressure gradient
[mmHg]
Flow
rate
[L/min]
Luminal
area
[mm2]
FloWatch1-PAB with
26% occlusion
15.26 2 47
Corresponding circular
banding (neck 7.77 mm)
17.55 2 47
FloWatch1-PAB with
50% occlusion
14.23 1.5 39
Corresponding circular
banding (neck 7.06 mm)
14.85 1.5 39results confirm the clinical observation that the pressure
gradients in correspondence of the banding are only
minimally influenced by the shape of the banding, at least
in the simulated range. After FloWatch1-PAB removal, we
assume that the pulmonary artery reopens to a circular
restricted configuration with a restriction luminal perimeter
corresponding to the perimeter during the banding process
with FloWatch1-PAB. This restriction luminal perimeter is
34 mm corresponding to a luminal diameter of 10.86 mm at
the restriction neck. Numerical simulations demonstrate that
the pressure gradient caused by this restriction is in the range
of 2.5 mmHg for a physiologic realistic flow rate of 1.5 L/min
after surgical repair.
A comparison of the axial flow velocity with FloWatch1-
PAB and the conventional circular banding is shown in Fig. 4.
3.3. Clinical data
The mean internal diameter of the pulmonary artery at
the time of banding was 13.3  4.5 mm (range 7—20 mm).
After a mean interval of 5.9  3.7 months (range 3—14
months), with the mean percentage narrowing of the device
set at 53% (range from 25 to 90%, dictated by the initial
diameter of the pulmonary artery and the clinical needs), all
children underwent intra-cardiac repair and FloWatch1-PAB
removal. In all patients the declipping of the FloWatch1-PAB
was immediately followed by spontaneous reopening of the
main pulmonary artery. The intra-operative aspect of the
wall of the main pulmonary artery was in all cases with very
pliable and soft tissues, completely different from the thick,
fibrotic ring left in place by conventional pulmonary artery
banding. As a consequence, reconstruction of the pulmonary
artery was required in no patient. The presence of a thin and
pliable pulmonary artery wall has been confirmed in two
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Fig. 5. Intra-operative trans-oesophageal echocardiography, showing the
narrowing of the pulmonary artery (A = 0.46 cm) with FloWatch1-PAB in situ,
the spontaneous reopening of the pulmonary artery (B = 1.09 cm) immedi-
ately after unclipping the FloWatch1-PAB, and with the colour Doppler
(C = 1.10 cm) showing absence of pressure gradient. Ao: aorta; and PA:
pulmonary artery.children where trans-section was required for the intra-
cardiac repair (arterial switch).
The mean internal diameter of the main pulmonary artery
with simple FloWatch1-PAB removal increased from
3.0  0.8 mm (range 3—5 mm) to 12.4  4.5 mm (range 7—
20 mm) (Fig. 5).
These values have been compared with the values of the
normal internal diameter of the main pulmonary artery in
children with the same age: 9.9  1.6 mm (range 8.4—
13.0 mm) and a statistical difference could not be demon-
strated (P = 0.30).
The measured values have been reported in Fig. 6, with
the relationship between the recorded pulmonary artery
perimeters (Fig. 6A) and the corresponding cross-sectional
areas (Fig. 6B), together with the comparison with the
normal values for the age.
Even with a relatively small and highly non-homogenous
group, there is a significant difference (P < 0.05) between
the pulmonary artery cross-sectional area with FloWatch1-
PAB in place in comparison to all other groups. This is relevant
because this cross-section include the arterial wall which is
not expected to change, thus, the effective lumen cross-
sectional area has to change in a very substantial way to
ensure this significant difference. As the thickness of the
pulmonary artery was not accurately measured, it was
impossible to exclude the arterial wall from this cross-
sectional area.Fig. 6. Clinical data: variations of the pulmonary artery perimeters (A) and the
corresponding cross-sectional areas (B), before implantation of FloWatch1-
PAB, with the device in situ and immediately after explantation, together with
the comparison with the normal values for the age. Error bars indicate
standard deviation (n = 7). Statistically different from all other groups
(*P < 0.05). Statistically different from group before implantation (§P < 0.05).
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size of the pulmonary artery from the normal population is
the group of patients before banding.
No residual pressure gradient was recorded in correspon-
dence of the site of the previous FloWatch1-PAB implanta-
tion in six patients, while 10 mmHg peak pressure gradient
and 5 mmHgmean gradient were recorded in the last patient.
These values remained unchanged during a mean follow-up
after FloWatch1-PAB removal of 18.2 months (range 14—24
months).
This absence of residual pressure gradient after simple
FloWatch1-PAB removal, without reconstruction of the
pulmonary artery, is in agreement with the very small
theoretical values obtained with our CFD model (in the range
of 2.5 mmHg for a flow rate of 1.5 L/min).4. Discussion
The proven clinical availability of a telemetrically
controlled adjustable pulmonary artery banding for neonates
and infants [10—13] has already extended the potential
indications to pulmonary artery banding, particularly
because of the possibility of endless adjustments repeated
over long term, from the limited classical [1,2] to more
controversial indications [3,4]. The horizon of the indications
for pulmonary artery banding can be further expanded to
more difficult situations [5—9].
In this study, we have observed the possibility of avoiding
the pulmonary artery reconstruction at the time of intra-
cardiac repair; thanks to the utilization of the adjustable
pulmonary artery banding with FloWatch1-PAB. Our findings
constitute a further improvement in comparison with the
generally reported clinical experience with the conventional
banding, where reconstruction of the pulmonary artery is the
rule, not infrequently accompanied by the need of further
surgical and/or interventional treatment because of residual
pressure gradient in the correspondence of the pulmonary
artery reconstruction [15—18,21].
The reason for the different behaviour of the pulmonary
artery when narrowed by a FloWatch1-PAB versus a
conventional banding could have been found in either the
materials used for the banding and/or in the shape of the
narrowing.
Since the tissue fibrosis precluding spontaneous expansion
after de-banding has been found independently on the
materials used for the banding in the literature [15—18,22] as
well as in our personal clinical experience, we concentrated
our study on the shape of the banding.
While the conventional banding produces a circular
narrowing of the main pulmonary artery with the internal
shape corresponding to a circular cross-sectional area, due
to the shape of FloWatch1-PAB the internal shape of the
pulmonary artery became a source of banana-shape, close
to a crescent shape, and is the fact that this banana-
shape is a concave shape which provides its remarkable
properties.
The FloWatch1-PAB allows for the same reduction of the
cross-sectional pulmonary artery area than the conventional
circular banding, but with a significantly larger perimeter;
thanks to the banana-shape of the circumference. Further-more, the perimeter remains constant for the entire range of
regulation of the banding (Fig. 2).
Our understanding is that after conventional circular
banding the substantial reduction of the perimeter of the
pulmonary arterial wall is accompanied by anatomical and
histological changes with increased thickness, dense fibrosis
and loss of elasticity. After removal of the conventional band,
the wall of the pulmonary artery remains fixed in the same
position and it is impossible to increase the cross-sectional
area without changing its diameter. Therefore, a surgical
incision/resection with subsequent reconstruction is man-
datory, sometimes with residual or recurrent pressure
gradient [15—18,21].
Since the banding with FloWatch1-PAB obtains the same
reduction of cross-sectional area of the conventional circular
banding, and therefore the same pressure gradient, without
any reduction of the perimeter of the pulmonary artery, the
wall of the artery can maintain intact its anatomical
properties without any reduction of elasticity. Therefore,
the simple FloWatch1-PAB removal at the time of intra-
cardiac repair is enough to obtain spontaneous and complete
expansion of the wall of the pulmonary artery up to a circular
cross-sectional area with the same perimeter of the
previously banded pulmonary artery, with maintenance of
its elasticity and pliability.
In a previously reported experimental study in animals the
conventional pulmonary artery banding had been compared
with an adjustable, stainless steel ‘‘ball and saddle’’ device
[22]. Interestingly, this prosthesis induced a crescent shape of
the pulmonary artery narrowing, very similar to the one
obtained with the FloWatch1-PAB [22]. The authors of this
experimental study observed that, while ‘‘unbanding with
either umbilical or Teflon tape narrowingwas difficult because
of marked fibrosis and scarring around the circumferential
tape’’, ‘‘unbanding of the ball and saddle prosthesis was
readily accomplished and resulted in restoration of the
prebanded lumen and abolition of the pressure gradient
across the previously banded main pulmonary artery’’ [22].
Theauthors also concluded that ‘‘wehavenot and shall not use
the currently described ball and saddle prosthesis clinically’’,
because of the observed ‘‘atrophy of the vessel wall beneath
the metal band’’ after a 3-month period of implantation [22].
In our model of adjustable pulmonary artery banding,
realised without being aware of the above previous study
[22], because of the progresses in the development of
biomaterials, structural damages to the wall of the
pulmonary artery have been not found, even with the
FloWatch1-PAB remaining implanted for amean duration of 6
months, and the range of duration extended up to 14 months.
The same phenomenon had already been observed in the
previous experimental study in piglets, where the wall of the
pulmonary artery maintained a rather intact histology [14].
While we have data from the animal study, at the present
time evidence of the maintenance of the histological
morphology of the pulmonary artery with FloWatch1-PAB
is not yet available in patients.
The absence of measurable residual pressure gradients
recorded in our patients after simple FloWatch1-PAB
removal, without reconstruction of the pulmonary artery,
is in total agreement with the results obtained with the CFD
model.
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suggest that the non-circular shape of the banding allows
for a smaller jet effect than conventional banding (Fig. 4).
The CFD also shows, for the same gradient and flow, a faster
decrease of the maximal axial velocity; this observation
could have a clinical correspondence in a reduced
traumatic jet lesion at the level of the pulmonary artery
bifurcation.
Despite several studies have previously been reported
with the use of the CFD to investigate problems related with
surgery of congenital heart defects [23—25], to our knowl-
edge the CFD has never been utilised before to study the
effects of different shapes of pulmonary artery banding.
Our observations confirm that CFD can provide valid
support to investigate clinical problems, in order to find
solutions then validated by the clinical evidence.5. Conclusions
Based on the results of our study with geometrical analysis
and CFD model, with the data confirmed by the clinical
evidence, we can conclude that pulmonary artery banding
can be performed replacing the conventional circular
narrowing with the non-circular shape of FloWatch1-PAB,
with the following advantages in addition to the ones already
recognised to the telemetrically adjustable banding [10—13]:(a) the pressure gradient will remain essentially the same as
for the conventional circular banding for any given cross-
sectional area, but with a reduction of the perimeter of
the pulmonary artery significantly smaller; and(b) reconstruction of the pulmonary artery at the time of de-
banding for intra-cardiac repair can be avoided.Acknowledgements
Drs. Nicole Sekarski and Marc-Andre´ Bernath kindly
provided the echocardiographic illustrations. The numerical
simulations have been carried out using the finite element
library LifeV.
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